PMA Review Costs Pooled In Unit-Cost Analysis; CDRH To Monitor Modules
This article was originally published in The Gray Sheet
Executive Summary
FDA's cost study of its device review resources likely will consolidate labor data for traditional, modular, expedited and panel-track PMAs into one cohort, rather than track each application type separately